{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:55:41Z","timestamp":1775487341302,"version":"3.50.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myeloproliferative neoplasms (MPNs) comprise a heterogeneous group of clonal hematopoietic stem cell disorders with distinct molecular pathogenesis and treatment strategies. Across all MPN subtypes, patients experience a substantial and persistent symptom burden that impairs health-related quality of life (HrQoL). Because MPNs are typically chronic diseases, lifelong symptom management and supportive therapies play a central role in patient care. Supportive care primarily targets disease- and treatment-related symptoms rather than the underlying malignancy itself. However, it remains unclear whether symptom profiles are comparable across MPN subtypes independent of disease phenotype. Therefore, this analysis aimed to identify symptom severity clusters (SSCs) in a cohort of patients with MPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicenter cross-sectional survey was conducted. Patients with MPN aged \u226518 years completed questionnaires assessing sociodemographic and disease-specific variables (e.g., sex, age, diagnosis, and current therapies) as well as the severity of 14 symptoms (e.g., fatigue, musculoskeletal pain, and itching), rated on continuous scales ranging from 0 (absent) to 100 (worst imaginable). Hierarchical and K-means cluster analysis as well as multinomial logistic regression were used to identify SSCs and their associations with patient characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sample comprised 644 patients (63% female; mean age 56.8 \u00b1 13.4 years), including 187 patients with chronic myeloid leukemia, 174 with polycythemia vera, 154 with essential thrombocythemia, and 129 with myelofibrosis. Four SSCs were identified: very high, high, middle, and low symptom severity. Compared with the low SSC, membership in the very high SSC was associated with younger age (95% CI: \u22120.04 to 0.00) and lower educational level (95% CI: \u22121.17 to \u22120.04). Membership in the high SSC was associated with female sex (95% CI: 1.26 to 2.60), higher body mass index (95% CI: 0.00 to 0.11), and lower educational level (95% CI: \u22121.20 to \u22120.19). Membership in the very high, high, or middle SSCs, compared with the low SSC, was not associated with diagnostic group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Symptom severity in patients with MPN appears to be comparable across disease subtypes. These findings support a shift toward symptom-focused, multimodal supportive care approaches (e.g., exercise and psychological support) in patients with MPN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1802050","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:21:29Z","timestamp":1774243289000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97)"],"prefix":"10.3389","volume":"16","author":[{"given":"Sabine","family":"Felser","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Clinic for Hematology, Hemostaseology, Oncology, Stem Cell Therapy and Palliative Care, Rostock University Medical Center","place":["Rostock, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Koeppel","sequence":"additional","affiliation":[{"name":"Working Group Exercise Oncology, Department of Medical Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, National Center for Tumor Diseases Heidelberg, a partnership between DKFZ and Heidelberg University Hospital","place":["Heidelberg, Germany"]},{"name":"Deutscher Verband f\u00fcr Gesundheitssport und Sporttherapie (DVGS) e.V.","place":["H\u00fcrt-Efferen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rea","family":"Kuehl","sequence":"additional","affiliation":[{"name":"Working Group Exercise Oncology, Department of Medical Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, National Center for Tumor Diseases Heidelberg, a partnership between DKFZ and Heidelberg University Hospital","place":["Heidelberg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"le Coutre","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology","place":["Berlin, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa K.","family":"Al-Ali","sequence":"additional","affiliation":[{"name":"Krukenberg Cancer Center Halle (Saale), University Hospital Halle","place":["Halle (Saale), Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susann","family":"Schulze","sequence":"additional","affiliation":[{"name":"Krukenberg Cancer Center Halle (Saale), University Hospital Halle","place":["Halle (Saale), Germany"]},{"name":"Department of Medicine Clinic II, Hematology, Oncology, Palliative Medicine, Carl-von-Basedow-Klinikum","place":["Merseburg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-Olof","family":"Muegge","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heinrich Braun Klinikum Zwickau","place":["Zwickau, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Bormann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Clinic for Hematology, Hemostaseology, Oncology, Stem Cell Therapy and Palliative Care, Rostock University Medical Center","place":["Rostock, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Geissler","sequence":"additional","affiliation":[{"name":"Leukaemie-Online\/LeukaNET e.V","place":["Riemering, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Dadgar","sequence":"additional","affiliation":[{"name":"mpn-netzwerk e. V.","place":["Bonn, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Junghanss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Clinic for Hematology, Hemostaseology, Oncology, Stem Cell Therapy and Palliative Care, Rostock University Medical Center","place":["Rostock, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Ulbricht","sequence":"additional","affiliation":[{"name":"Institut for Community Medicine, Department SHIP-KEF, University Medicine Greifswald","place":["Greifswald, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26503","article-title":"Classification of myeloid neoplasms\/acute leukemia: Global perspectives and the international consensus classification approach","volume":"97","author":"Arber","year":"2022","journal-title":"Am J Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"iv261","DOI":"10.1093\/annonc\/mdx219","article-title":"Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Hochhaus","year":"2018","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am J Hematol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26050","article-title":"Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management","volume":"96","author":"Tefferi","year":"2021","journal-title":"Am J Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-206143","article-title":"Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN)","volume":"39","author":"Manz","year":"2025","journal-title":"Leukemia"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000966","article-title":"Patient-reported outcomes and quality of life in anemic and symptomatic patients with myelofibrosis: Results from the MOMENTUM study","volume":"7","author":"Mesa","year":"2023","journal-title":"HemaSphere"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-025-01234-8","article-title":"Symptom burden in myeloproliferative neoplasms: Clinical correlates, dynamics, and survival impact\u2014a study of 784 patients from the Quebec MPN research group","volume":"15","author":"Poullet","year":"2025","journal-title":"Blood Cancer J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00520-025-09451-4","article-title":"Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: A systematic review and meta-analysis","volume":"33","author":"Smit","year":"2025","journal-title":"Support Care Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1808","article-title":"A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors","volume":"7","author":"Zulbaran-Rojas","year":"2018","journal-title":"Cancer Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1188\/20.onf.498-511","article-title":"Guideline-recommended symptom management strategies that cross over two or more cancer symptoms","volume":"47","author":"Kwekkeboom","year":"2020","journal-title":"Oncol Nurs Forum"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104718","article-title":"Physical activity guidelines in oncology: A systematic review of the current recommendations","volume":"210","author":"Avancini","year":"2025","journal-title":"Crit Rev Oncology\/Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2024-109392","article-title":"Impact of exercise on health outcomes in people with cancer: An umbrella review of systematic reviews and meta-analyses of randomised controlled trials","volume":"59","author":"Bai","year":"2025","journal-title":"Br J Sports Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13050467","article-title":"The effect of exercise-based interventions on health-related quality of life of patients with hematological Malignancies: A systematic review and meta-analysis","volume":"13","author":"Borsati","year":"2025","journal-title":"Healthcare (Basel Switzerland)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1249\/mss.0000000000002116","article-title":"Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med Sci Sports Exercise"},{"key":"B16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12906-019-2530-8","article-title":"Online yoga in myeloproliferative neoplasm patients: Results of a randomized pilot trial to inform future research","volume":"19","author":"Huberty","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2196\/12662","article-title":"Smartphone-based meditation for myeloproliferative neoplasm patients: Feasibility study to inform future trials","volume":"3","author":"Huberty","year":"2019","journal-title":"JMIR Format Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12865","article-title":"The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-an explorative study","volume":"27","author":"Pedersen","year":"2018","journal-title":"Eur J Cancer Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd009075.pub3","article-title":"Aerobic physical exercise for adult patients with haematological Malignancies","volume":"1","author":"Knips","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41408-023-00861-3","article-title":"Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy","volume":"13","author":"Janssen","year":"2023","journal-title":"Blood Cancer J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2752-3","article-title":"A systematic review on the use of exercise interventions for individuals with myeloid leukemia","volume":"23","author":"Smith-Turchyn","year":"2015","journal-title":"Support Care Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6413","article-title":"Physical exercise recommendations for patients with polycythemia vera based on preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)","volume":"12","author":"Felser","year":"2023","journal-title":"Cancer Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1345050","article-title":"Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)","volume":"14","author":"Hollenbach","year":"2024","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328955","article-title":"The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International prospective validation and reliability trial in 402 patients","volume":"118","author":"Scherber","year":"2011","journal-title":"Blood"},{"key":"B26","first-page":"20003","article-title":"Single-linkage method to detect multiple outliers with different outlier scenarios in circular regression model","author":"Satari","year":"2019"},{"key":"B27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/096228029200100103","article-title":"Cluster analysis and related techniques in medical research","volume":"1","author":"McLachlan","year":"1992","journal-title":"Stat Methods Med Res"},{"key":"B28","article-title":"Some methods for classification and analysis of multivariate observations","volume-title":"Proceedings of the 5th Berkeley Symposium on Mathematical Statistics and Probability","author":"MacQueen","year":"1967"},{"key":"B29","volume-title":"SILHOUETTE: Stata module to calculate and graph silhouette width for cluster analysis: Statistical Software Components S458165","author":"Halpin","year":"2016"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/pon.6338","article-title":"The personal impact of living with a myeloproliferative neoplasm","volume":"33","author":"Eppingbroek","year":"2024","journal-title":"Psycho-Oncology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17182987","article-title":"Exploring physical activity levels, barriers, and education sources in people with cancer undergoing chemotherapy","volume":"17","author":"Cesnik","year":"2025","journal-title":"Cancers"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000093479.39115.af","article-title":"Health-related quality of life in a multiethnic sample of middle-aged women: Study of Women's Health Across the Nation (SWAN)","volume":"41","author":"Avis","year":"2003","journal-title":"Med Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.amjmed.2005.10.008","article-title":"Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women's lives","author":"Woods","year":"2005","journal-title":"Am J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0b013e318214f0de","article-title":"Duration of menopausal hot flushes and associated risk factors","volume":"117","author":"Freeman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3324\/haematol.2016.149559","article-title":"Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: An analysis by the MPN QOL International Working Group","volume":"102","author":"Geyer","year":"2017","journal-title":"Haematologica"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000018079","article-title":"Variables associated with patient-reported symptoms in persons with chronic phase chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy","volume":"98","author":"Yu","year":"2019","journal-title":"Medicine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3082-y","article-title":"The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: Results from the international MPN Landmark survey","volume":"96","author":"Harrison","year":"2017","journal-title":"Ann Hematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18329","article-title":"Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)-I study","volume":"198","author":"Kosiorek","year":"2022","journal-title":"Br J Haematol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.6914","article-title":"Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: A meta-analysis","volume":"3","author":"Mustian","year":"2017","journal-title":"JAMA Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-023-01862-9","article-title":"The effect of exercise on pain in people with cancer: A systematic review with meta-analysis","volume":"53","author":"Plinsinga","year":"2023","journal-title":"Sports Med (Auckland NZ)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.12.021","article-title":"Psychological and non-pharmacologic treatments for pain in cancer patients: A systematic review and meta-analysis","volume":"63","author":"Ruano","year":"2022","journal-title":"J Pain Symptom Manage"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3390\/cancers12082202","article-title":"Body mass index and total symptom burden in myeloproliferative neoplasms discovery of a U-shaped association","volume":"12","author":"Christensen","year":"2020","journal-title":"Cancers"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae025","article-title":"Obesity and cardiovascular health","volume":"31","author":"Welsh","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0380-1","article-title":"Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: A systematic review and dose response meta-analysis","volume":"33","author":"Patterson","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0000000000002198","article-title":"Association between vasomotor symptom frequency and weight gain in the Study of Women's Health Across the Nation","volume":"30","author":"Gibson","year":"2023","journal-title":"Menopause (New York NY)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11764-016-0594-8","article-title":"Toward the optimal strategy for sustained weight loss in overweight cancer survivors: A systematic review of the literature","volume":"11","author":"Hoedjes","year":"2017","journal-title":"J Cancer Survivorship"},{"key":"B47","volume-title":"WHO Guidelines on Physical Activity and Sedentary Behaviour","year":"2020"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2022.13.2.4","article-title":"Cardiovascular adverse events and mitigation strategies for chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy","volume":"13","author":"Nodzon","year":"2022","journal-title":"J Adv Practitioner Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bvth.2025.100051","article-title":"Cardiovascular risk factors in myeloproliferative neoplasms: Associations with survival and thrombotic outcomes","volume":"2","author":"How","year":"2025","journal-title":"Blood Vessels Thromb Hemostasis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34103","article-title":"Improved survival of patients with myelofibrosis in the last decade: Single-center experience","volume":"128","author":"Masarova","year":"2022","journal-title":"Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1630-5","article-title":"Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison [eng","volume":"21","author":"Phillips","year":"2013","journal-title":"Support Care Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/clep.s162688","article-title":"Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark","volume":"11","author":"Brochmann","year":"2019","journal-title":"Clin Epidemiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12740\/pp\/onlinefirst\/202763","article-title":"Por\u00f3wnanie objaw\u00f3w depresyjnych mi\u0119dzy chorymi na nowotwory mieloproliferacyjne bez chromosomu Philadelphia leczonymi interferonem alfa a chorymi na PBSz leczonymi inhibitorami kinazy tyrozynowej. [Comparison of depressive symptoms between patients with myeloproliferative neoplasms without the Philadelphia chromosome treated with interferon alpha and patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors] [eng","author":"Gibek","year":"2025","journal-title":"Psychiatria Polska"}],"updated-by":[{"DOI":"10.3389\/fonc.2026.1837022","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1802050\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:51:53Z","timestamp":1775483513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1802050\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":53,"alternative-id":["10.3389\/fonc.2026.1802050"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1802050","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"1802050"}}